Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Japan Tobacco Inc.
DescriptionOral hypoxia-inducible factor prolyl hydroxylase domain inhibitor (HIF-PHD) inhibitor containing protein
Molecular Target Hypoxia-inducible factor 1 (HIF1)
Mechanism of ActionHypoxia-inducible factor prolyl hydroxylase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAnemia
Indication DetailsTreat anemia in patients with chronic kidney disease (CKD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today